CA2908497A1 - Endoprothese vasculaire a film mince pour arteriopathie - Google Patents

Endoprothese vasculaire a film mince pour arteriopathie

Info

Publication number: CA2908497A1
Authority: CA; Canada
Prior art keywords: stent; recited; fenestrations; sheet; implant
Prior art date: 2013-02-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA2908497A

Other languages

English (en)

Inventor

Daniel S. Levi

Gregory P. Carman

Youngjae Chun

Allan W. Tulloch

Colin Kealey

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of California San Diego UCSD

Original Assignee

University of California San Diego UCSD

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-02-25

Filing date

2014-02-25

Publication date

2014-08-28

2014-02-25 Application filed by University of California San Diego UCSD filed Critical University of California San Diego UCSD

2014-08-28 Publication of CA2908497A1 publication Critical patent/CA2908497A1/fr

Status Abandoned legal-status Critical Current

Links

239000010409 thin film Substances 0.000 title claims abstract description 32
200000000007 Arterial disease Diseases 0.000 title claims description 4
230000002792 vascular Effects 0.000 title description 3
238000013508 migration Methods 0.000 claims description 14
230000005012 migration Effects 0.000 claims description 13
230000035992 intercellular communication Effects 0.000 claims description 9
238000011282 treatment Methods 0.000 claims description 8
HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 claims description 3
208000005764 Peripheral Arterial Disease Diseases 0.000 claims description 2
208000030831 Peripheral arterial occlusive disease Diseases 0.000 claims description 2
239000007943 implant Substances 0.000 claims 17
210000004204 blood vessel Anatomy 0.000 claims 6
230000005660 hydrophilic surface Effects 0.000 claims 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
229910001000 nickel titanium Inorganic materials 0.000 abstract description 34
HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 abstract description 34
230000024353 muscle cell migration Effects 0.000 abstract 1
238000000034 method Methods 0.000 description 19
230000003511 endothelial effect Effects 0.000 description 17
239000010410 layer Substances 0.000 description 17
210000000329 smooth muscle myocyte Anatomy 0.000 description 17
208000007536 Thrombosis Diseases 0.000 description 13
239000010408 film Substances 0.000 description 13
208000030613 peripheral artery disease Diseases 0.000 description 13
230000000694 effects Effects 0.000 description 12
239000000758 substrate Substances 0.000 description 12
230000012010 growth Effects 0.000 description 10
230000004888 barrier function Effects 0.000 description 9
208000034827 Neointima Diseases 0.000 description 8
230000008901 benefit Effects 0.000 description 7
238000000708 deep reactive-ion etching Methods 0.000 description 7
238000000151 deposition Methods 0.000 description 7
230000008021 deposition Effects 0.000 description 7
206010020718 hyperplasia Diseases 0.000 description 7
210000003090 iliac artery Anatomy 0.000 description 7
239000002356 single layer Substances 0.000 description 7
230000008569 process Effects 0.000 description 6
208000037803 restenosis Diseases 0.000 description 6
238000009736 wetting Methods 0.000 description 6
208000031481 Pathologic Constriction Diseases 0.000 description 5
230000036262 stenosis Effects 0.000 description 5
208000037804 stenosis Diseases 0.000 description 5
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
KPKZJLCSROULON-QKGLWVMZSA-N Phalloidin Chemical compound N1C(=O)[C@@H]([C@@H](O)C)NC(=O)[C@H](C)NC(=O)[C@H](C[C@@](C)(O)CO)NC(=O)[C@H](C2)NC(=O)[C@H](C)NC(=O)[C@@H]3C[C@H](O)CN3C(=O)[C@@H]1CSC1=C2C2=CC=CC=C2N1 KPKZJLCSROULON-QKGLWVMZSA-N 0.000 description 4
210000001367 artery Anatomy 0.000 description 4
230000017531 blood circulation Effects 0.000 description 4
238000004891 communication Methods 0.000 description 4
238000010586 diagram Methods 0.000 description 4
238000000338 in vitro Methods 0.000 description 4
238000001727 in vivo Methods 0.000 description 4
230000015590 smooth muscle cell migration Effects 0.000 description 4
238000012360 testing method Methods 0.000 description 4
102000009123 Fibrin Human genes 0.000 description 3
108010073385 Fibrin Proteins 0.000 description 3
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
241001494479 Pecora Species 0.000 description 3
230000012292 cell migration Effects 0.000 description 3
229950003499 fibrin Drugs 0.000 description 3
230000006870 function Effects 0.000 description 3
238000004949 mass spectrometry Methods 0.000 description 3
229910001092 metal group alloy Inorganic materials 0.000 description 3
238000000879 optical micrograph Methods 0.000 description 3
238000004626 scanning electron microscopy Methods 0.000 description 3
238000007789 sealing Methods 0.000 description 3
FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
206010060965 Arterial stenosis Diseases 0.000 description 2
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
108010009711 Phalloidine Proteins 0.000 description 2
241000282898 Sus scrofa Species 0.000 description 2
230000001154 acute effect Effects 0.000 description 2
230000032683 aging Effects 0.000 description 2
210000002403 aortic endothelial cell Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
230000010261 cell growth Effects 0.000 description 2
230000004663 cell proliferation Effects 0.000 description 2
210000002889 endothelial cell Anatomy 0.000 description 2
230000035876 healing Effects 0.000 description 2
238000002173 high-resolution transmission electron microscopy Methods 0.000 description 2
230000003902 lesion Effects 0.000 description 2
238000007479 molecular analysis Methods 0.000 description 2
229910017604 nitric acid Inorganic materials 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
230000035699 permeability Effects 0.000 description 2
239000011148 porous material Substances 0.000 description 2
230000035755 proliferation Effects 0.000 description 2
230000004044 response Effects 0.000 description 2
238000000926 separation method Methods 0.000 description 2
210000002460 smooth muscle Anatomy 0.000 description 2
238000004544 sputter deposition Methods 0.000 description 2
230000035882 stress Effects 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000004381 surface treatment Methods 0.000 description 2
238000001039 wet etching Methods 0.000 description 2
239000012103 Alexa Fluor 488 Substances 0.000 description 1
201000001320 Atherosclerosis Diseases 0.000 description 1
208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
238000012276 Endovascular treatment Methods 0.000 description 1
241000308582 Gonostoma elongatum Species 0.000 description 1
206010051269 Graft thrombosis Diseases 0.000 description 1
102000001554 Hemoglobins Human genes 0.000 description 1
108010054147 Hemoglobins Proteins 0.000 description 1
206010022562 Intermittent claudication Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
238000002266 amputation Methods 0.000 description 1
238000003491 array Methods 0.000 description 1
208000028922 artery disease Diseases 0.000 description 1
238000003556 assay Methods 0.000 description 1
230000000778 atheroprotective effect Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000009141 biological interaction Effects 0.000 description 1
239000012620 biological material Substances 0.000 description 1
239000010836 blood and blood product Substances 0.000 description 1
229940125691 blood product Drugs 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
230000010267 cellular communication Effects 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
229910052804 chromium Inorganic materials 0.000 description 1
239000011651 chromium Substances 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
229910003460 diamond Inorganic materials 0.000 description 1
239000010432 diamond Substances 0.000 description 1
210000003989 endothelium vascular Anatomy 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000001105 femoral artery Anatomy 0.000 description 1
239000012530 fluid Substances 0.000 description 1
230000036541 health Effects 0.000 description 1
230000013632 homeostatic process Effects 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
238000002513 implantation Methods 0.000 description 1
238000010874 in vitro model Methods 0.000 description 1
210000004969 inflammatory cell Anatomy 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
230000003993 interaction Effects 0.000 description 1
208000021156 intermittent vascular claudication Diseases 0.000 description 1
230000001788 irregular Effects 0.000 description 1
201000002818 limb ischemia Diseases 0.000 description 1
230000007774 longterm Effects 0.000 description 1
210000003141 lower extremity Anatomy 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
239000002184 metal Substances 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000000203 mixture Substances 0.000 description 1
PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
230000001453 nonthrombogenic effect Effects 0.000 description 1
230000003076 paracrine Effects 0.000 description 1
238000002161 passivation Methods 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
230000007170 pathology Effects 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
230000035479 physiological effects, processes and functions Effects 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
-1 polytetrafluoroethylene Polymers 0.000 description 1
229920001343 polytetrafluoroethylene Polymers 0.000 description 1
239000004810 polytetrafluoroethylene Substances 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000000770 proinflammatory effect Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
238000001878 scanning electron micrograph Methods 0.000 description 1
239000004065 semiconductor Substances 0.000 description 1
229910001285 shape-memory alloy Inorganic materials 0.000 description 1
230000011664 signaling Effects 0.000 description 1
230000003746 surface roughness Effects 0.000 description 1
230000002885 thrombogenetic effect Effects 0.000 description 1
239000010936 titanium Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
- A61F2002/0086—Special surfaces of prostheses, e.g. for improving ingrowth for preferentially controlling or promoting the growth of specific types of cells or tissues
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0076—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/16—Materials with shape-memory or superelastic properties

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Cardiology (AREA)
Oral & Maxillofacial Surgery (AREA)
Transplantation (AREA)
Epidemiology (AREA)
Physics & Mathematics (AREA)
Optics & Photonics (AREA)
Chemical & Material Sciences (AREA)
Inorganic Chemistry (AREA)
Surgery (AREA)
Prostheses (AREA)
Materials For Medical Uses (AREA)

CA2908497A 2013-02-25 2014-02-25 Endoprothese vasculaire a film mince pour arteriopathie Abandoned CA2908497A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201361769042P	2013-02-25	2013-02-25
US61/769,042		2013-02-25
PCT/US2014/018410 WO2014131037A1 (fr)	2013-02-25	2014-02-25	Endoprothèse vasculaire à film mince pour artériopathie

Publications (1)

Publication Number	Publication Date
CA2908497A1 true CA2908497A1 (fr)	2014-08-28

Family

ID=51391919

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2908497A Abandoned CA2908497A1 (fr)	2013-02-25	2014-02-25	Endoprothese vasculaire a film mince pour arteriopathie

Country Status (4)

Country	Link
EP (1)	EP2958526A4 (fr)
JP (1)	JP6462592B2 (fr)
CA (1)	CA2908497A1 (fr)
WO (1)	WO2014131037A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3060176B1 (fr) *	2013-10-23	2018-12-05	NSVascular, Inc	Dispositifs tridimensionnels à base de nitinol en couche mince
WO2016210380A1 (fr)	2015-06-26	2016-12-29	Nsvascular, Inc.	Revêtements à micro-maille à film mince pour dispositifs médicaux, et procédés associés
EP3316827B1 (fr)	2015-07-02	2023-10-11	Monarch Biosciences, Inc.	Dispositifs médicaux à micro-filet à film mince et procédés associés

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6120535A (en) *	1996-07-29	2000-09-19	Radiance Medical Systems, Inc.	Microporous tubular prosthesis
US6398803B1 (en) *	1999-02-02	2002-06-04	Impra, Inc., A Subsidiary Of C.R. Bard, Inc.	Partial encapsulation of stents
US6334868B1 (en) *	1999-10-08	2002-01-01	Advanced Cardiovascular Systems, Inc.	Stent cover
US7736687B2 (en) *	2006-01-31	2010-06-15	Advance Bio Prosthetic Surfaces, Ltd.	Methods of making medical devices
US20060052865A1 (en) *	2004-09-09	2006-03-09	Banas Christopher E	Stents with metallic covers and methods of making same
WO2001053559A1 (fr) *	2000-01-24	2001-07-26	Smart Therapeutics, Inc.	Dispositif d'alliage a memoire de forme a couche mince et procede
US6790298B2 (en)	2000-07-10	2004-09-14	Tini Alloy Company	Method of fabrication of free standing shape memory alloy thin film
EP1549248A4 (fr) *	2002-09-26	2015-11-25	Advanced Bio Prosthetic Surfac	Films de l'alliage nitinol formes par depot sous vide et dotes d'une haute resistance, materiaux medicaux pour greffons a film mince et procede de fabrication correspondant
WO2005084583A2 (fr) *	2004-03-02	2005-09-15	Boston Scientific Scimed, Inc.	Dispositifs medicaux comprenant des pellicules metalliques et leurs procedes de fabrication
US20060142838A1 (en) *	2004-12-29	2006-06-29	Masoud Molaei	Medical devices including metallic films and methods for loading and deploying same
WO2008151204A1 (fr) *	2007-06-04	2008-12-11	Sequent Medical Inc.	Procédés et dispositifs pour le traitement de défauts vasculaires
BRPI1009556A2 (pt) *	2009-03-06	2019-09-24	Univ California	implanta vascular, método para gerar uma camada super hidrofílica sobre a superfície de um implante vascular, método de formar uma folha de película fina de níquel titânio, folha de película fina hidrofílica de níquel titânio, sistema e método para tratar uma condição vascular.
WO2011150118A2 (fr) *	2010-05-25	2011-12-01	The Regents Of The University Of California	Déviateur de flux à couverture fractionnelle ultra-faible destiné au traitement d'anévrismes et de maladies vasculaires

2014
- 2014-02-25 CA CA2908497A patent/CA2908497A1/fr not_active Abandoned
- 2014-02-25 EP EP14753541.3A patent/EP2958526A4/fr not_active Withdrawn
- 2014-02-25 WO PCT/US2014/018410 patent/WO2014131037A1/fr not_active Ceased
- 2014-02-25 JP JP2015559281A patent/JP6462592B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP2958526A1 (fr)	2015-12-30
JP6462592B2 (ja)	2019-01-30
WO2014131037A1 (fr)	2014-08-28
JP2016507345A (ja)	2016-03-10
EP2958526A4 (fr)	2016-10-05

Legal Events

Date	Code	Title	Description
2020-04-21	FZDE	Dead	Effective date: 20200225

Publication	Publication Date	Title
EP1620047B1 (fr)	2009-11-11	Greffons metalliques implantables et leur procede de fabrication
AU2002353068B2 (en)	2008-06-05	Layered stent-graft and methods of making the same
US11020254B2 (en)	2021-06-01	Thin-film micromesh covers for medical devices and related methods
JP5118042B2 (ja)	2013-01-16	薬物結晶を含有する移植用インプラント
AU2013331308B2 (en)	2018-03-29	Method for making topographical features on a surface of a medical device
Nishi et al.	2011	Development of microporous self-expanding stent grafts for treating cerebral aneurysms: designing micropores to control intimal hyperplasia
CA2908497A1 (fr)	2014-08-28	Endoprothese vasculaire a film mince pour arteriopathie
CN104780871B (zh)	2017-03-22	涉及沉积支承结构的装置和方法
US20160000553A1 (en)	2016-01-07	Thin film vascular stent for arterial disease
Geremia et al.	1997	Experimental arteriovenous fistulas: treatment with silicone-covered metallic stents.
US20080281410A1 (en)	2008-11-13	Method for Production of a Coated Endovascular Device
Zaworonkow et al.	2018	Evaluation of TiNi-based wire mesh implant for abdominal wall defect management
Chen et al.	2017	Assessment of endothelial cell growth behavior in thin film nitinol
CA2888925C (fr)	2025-09-16	Procede de fabrication de caracteristiques topographiques sur une surface d'un dispositif medical
Gordon et al.	2008	Serial late dilatations of expanded polytetrafluoroethylene‐covered stents in porcine aorta
Strecker et al.	2004	Development of a new intravascular low-profile device for exclusion of aortic aneurysm: an experimental pilot study
Abundes-Velasco et al.	2020	Design, manufacture and initial tests of a drug-eluting coronary stent
JP2005342105A (ja)	2005-12-15	ステント
WO2025065018A1 (fr)	2025-03-27	Conduits vasculaires avec microcanaux pour réduire la perte de cellules endothéliales
Chun	2009	Thin film nickel-titanium endovascular stent grafts for cerebral and aortic aneurysms
BRPI0211257B1 (pt)	2018-02-27	Aparelho para enxerto de um vaso sanguíneo, enxerto para um vaso sanguíneo, e, método para formação de um enxerto para inserção em um vaso sanguíneo